Opus Genetics Inc (NASDAQ:IRD) has a beta value of 0.27 and has seen 0.19 million shares traded in the last trading session. The company, currently valued at $35.67M, closed the last trade at $1.13 per share which meant it lost -$0.02 on the day or -1.74% during that session. The IRD stock price is -139.82% off its 52-week high price of $2.71 and 28.32% above the 52-week low of $0.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.18 million shares traded. The 3-month trading volume is 226.47K shares.
Opus Genetics Inc (NASDAQ:IRD) trade information
Sporting -1.74% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the IRD stock price touched $1.13 or saw a rise of 4.24%. Year-to-date, Opus Genetics Inc shares have moved -5.04%, while the 5-day performance has seen it change -1.74%. Over the past 30 days, the shares of Opus Genetics Inc (NASDAQ:IRD) have changed -3.42%. Short interest in the company has seen 0.62 million shares shorted with days to cover at 3.44.
Opus Genetics Inc (IRD) estimates and forecasts
The company’s shares have lost -9.60% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -6.57%.
3 analysts offering their estimates for the company have set an average revenue estimate of 11.1M for the current quarter. 1 have an estimated revenue figure of 2M for the next ending quarter. Year-ago sales stood 1.69M and 1.71M respectively for this quarter and the next, and analysts expect sales will grow by 556.67% for the current quarter and -6.57% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 53.36% over the past 5 years. Earnings growth for 2025 is a modest -76.09% while over the next 5 years, the company’s earnings are expected to increase by 13.28%.
IRD Dividends
Opus Genetics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Opus Genetics Inc (NASDAQ:IRD)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 2.14% shares in the company for having 675.82 shares of worth $0.76 million while later fund manager owns 288.95 shares of worth $0.33 million as of Sep 30, 2024, which makes it owner of about 0.92% of company’s outstanding stock.
